Details

Autor(en) / Beteiligte

• Werfel, Thomas
• Heratizadeh, Annice
• Aberer, Werner
• Augustin, Matthias
• Biedermann, Tilo
• Bauer, Andrea
• Fölster‐Holst, Regina
• Kahle, Julia
• Kinberger, Maria
• Nemat, Katja
• Neustädter, Irena
• Peters, Eva
• Kiedrowski, Ralph
• Schmid‐Grendelmeier, Peter
• Schmitt, Jochen
• Schwennesen, Thomas
• Simon, Dagmar
• Spindler, Thomas
• Traidl‐Hoffmann, Claudia
• Werner, Ricardo Niklas
• Wollenberg, Andreas
• Worm, Margitta
• Ott, Hagen

Titel

S3 Guideline Atopic dermatitis: Part 1 ‐ General aspects, topical and non‐drug therapies, special patient groups

Ist Teil von

• Journal der Deutschen Dermatologischen Gesellschaft, 2024-01, Vol.22 (1), p.137-153

Ort / Verlag

Germany: Wiley Subscription Services, Inc

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Summary This S3 guideline was created based on the European S3 guideline, with special consideration of the medical conditions in the German‐speaking region and incorporating additions from the previous German‐language version. The interdisciplinary guideline commission consisted of representatives from the German Dermatological Society, the Professional Association of German Dermatologists, the Austrian Society of Dermatology and Venereology, the Swiss Society of Dermatology and Venereology, the German Society for Allergology and Clinical Immunology, the German Society for Pediatric and Adolescent Medicine, the Professional Association of Pediatricians and Adolescent Medicine, the Society for Pediatric Allergology and Environmental Medicine, the German Society for Pediatric Rehabilitation and Prevention, the German Society for Psychosomatic Medicine and Medical Psychotherapy, the German Network for Health Services Research, the German Eczema Association and the German Allergy and Asthma Association. This first part of the guideline focuses on the definition and diagnostic aspects of atopic dermatitis (AD), addressing topical therapy as well as non‐pharmacological treatment approaches such as UV therapy, psychoeducational therapy, dietary interventions for AD, allergen immunotherapy for AD, and complementary medicine. This part of the guideline also covers specific aspects of AD in children and adolescents, during pregnancy and lactation, and in the context of family planning. Additionally, it addresses occupational aspects of AD and highlights the perspective of the patients. The second part of the guideline, published separately, addresses the systemic therapy of AD.